Correlation Between Mauna Kea and Sartorius Stedim

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Mauna Kea and Sartorius Stedim at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mauna Kea and Sartorius Stedim into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mauna Kea Technologies and Sartorius Stedim Biotech, you can compare the effects of market volatilities on Mauna Kea and Sartorius Stedim and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mauna Kea with a short position of Sartorius Stedim. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mauna Kea and Sartorius Stedim.

Diversification Opportunities for Mauna Kea and Sartorius Stedim

0.21
  Correlation Coefficient

Modest diversification

The 3 months correlation between Mauna and Sartorius is 0.21. Overlapping area represents the amount of risk that can be diversified away by holding Mauna Kea Technologies and Sartorius Stedim Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sartorius Stedim Biotech and Mauna Kea is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mauna Kea Technologies are associated (or correlated) with Sartorius Stedim. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sartorius Stedim Biotech has no effect on the direction of Mauna Kea i.e., Mauna Kea and Sartorius Stedim go up and down completely randomly.

Pair Corralation between Mauna Kea and Sartorius Stedim

Assuming the 90 days trading horizon Mauna Kea Technologies is expected to under-perform the Sartorius Stedim. In addition to that, Mauna Kea is 1.15 times more volatile than Sartorius Stedim Biotech. It trades about -0.38 of its total potential returns per unit of risk. Sartorius Stedim Biotech is currently generating about -0.01 per unit of volatility. If you would invest  18,775  in Sartorius Stedim Biotech on August 30, 2024 and sell it today you would lose (775.00) from holding Sartorius Stedim Biotech or give up 4.13% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Mauna Kea Technologies  vs.  Sartorius Stedim Biotech

 Performance 
       Timeline  
Mauna Kea Technologies 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Mauna Kea Technologies has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in December 2024. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.
Sartorius Stedim Biotech 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Sartorius Stedim Biotech has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong primary indicators, Sartorius Stedim is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Mauna Kea and Sartorius Stedim Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Mauna Kea and Sartorius Stedim

The main advantage of trading using opposite Mauna Kea and Sartorius Stedim positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mauna Kea position performs unexpectedly, Sartorius Stedim can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sartorius Stedim will offset losses from the drop in Sartorius Stedim's long position.
The idea behind Mauna Kea Technologies and Sartorius Stedim Biotech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.

Other Complementary Tools

Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Content Syndication
Quickly integrate customizable finance content to your own investment portal